
Olurotimi Mesubi MD
Adult Congenital Heart Disease, Cardiac Electrophysiology
Physician
Join to View Full Profile
301 Mason Lord DriveBaltimore, MD 21224
Are you Dr. Mesubi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Olurotimi Mesubi, MD is a cardiologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland, Iowa, and Ohio. He is affiliated with Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital.
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Cardiovascular Disease, 2012 - 2015
- The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine/Pediatrics, 2006 - 2010
- University of Ilorin Faculty of Health SciencesClass of 1998
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine
Certifications & Licensure
- MD State Medical License 2011 - 2025
- OH State Medical License 2006 - 2018
- OH State Medical License 2006 - 2018
- IA State Medical License 2012 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Publications & Presentations
PubMed
- 1 citationsGlobal Health Inequities in Electrophysiology Care: A State-of-the-Art Review.Keva Garg, Danish Iltaf Satti, Ritu Yadav, Jeffrey Brumfield, Constatine O Akwanalo
JACC. Advances. 2024-12-01 - SGLT2 inhibitors protect against diabetic cardiomyopathy and atrial fibrillation through a CaMKII independent mechanism.Alex Severino, Oscar E Reyes-Gaido, Pauline Nguyen, Ahmed Elkarim, Elizabeth D Luczak
Biorxiv. 2024-09-23 - 21 citationsAn improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.Oscar E Reyes Gaido, Nikoleta Pavlaki, Jonathan M Granger, Olurotimi O Mesubi, Bian Liu
Science Translational Medicine. 2023-06-21